Release Date: 11/03/19 10:07 Summary: Scheme of Arrangement and Demerger Price Sensitive: Yes Download Document 1.73MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%